Related Experiment Video
Updated: Dec 27, 2025
11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
13.0K
Author Correction: Clinical Implications of Sub-grouping HER2 Positive Tumors by Amplicon Structure and Co-amplified
Myriam Maoz1, Michal Devir1, Michal Inbar1
1Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
Scientific Reports
|February 29, 2020
Abstract:
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
